# Administration of IV Laronidase Post Bone Marrow Transplant in Hurler

> **NCT01173016** · PHASE1 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 11 (actual)

## Conditions studied

- Hurler Syndrome

## Interventions

- **DRUG:** Laronidase

## Key facts

- **NCT ID:** NCT01173016
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-29
- **Primary completion:** 2016-03-04
- **Final completion:** 2016-03-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173016, "Administration of IV Laronidase Post Bone Marrow Transplant in Hurler". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01173016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*